Discovery of novel chiral diazepines as bombesin receptor subtype-3 (BRS-3) agonists with low brain penetration

被引：13

作者：

Matsufuji, Tetsuyoshi ^{[1
]}

Shimada, Kousei ^{[1
]}

Kobayashi, Shozo ^{[1
]}

Kawamura, Asuka ^{[1
]}

Fujimoto, Teppei ^{[1
]}

Arita, Tsuyoshi ^{[1
]}

Hara, Takashi ^{[2
]}

Konishi, Masahiro ^{[2
]}

Abe-Ohya, Rie ^{[2
]}

Izumi, Masanori ^{[2
]}

Sogawa, Yoshitaka ^{[2
]}

Nagai, Youko ^{[3
]}

Yoshida, Kazuhiro ^{[3
]}

Takahashi, Hisashi ^{[1
]}

机构：

[1] Daiichi Sankyo Co Ltd, Med Chem Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

[2] Daiichi Sankyo Co Ltd, Cardiovasc Metab Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

[3] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2014年 / 24卷 / 03期

关键词：

Bombesin receptor subtype-3 (BRS-3) agonists; Diazepine; Brain penetration; TERT-BUTANESULFINYL IMINES; ASYMMETRIC-SYNTHESIS; AMINES; MK-5046; SYSTEM;

D O I：

10.1016/j.bmcl.2013.12.106

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The discovery and optimization of a novel series of BRS-3 agonists are described. We explored a potent BRS-3 agonist with low brain penetration to avoid an adverse effect derived from central nervous system exposure. Through the derivatization process, chiral diazepines 9f and 9g were identified as possessing low brain penetration as well as potent in vitro activity against human and mouse BRS-3s. (C) 2014 Elsevier Ltd. All rights reserved.

引用

页码：750 / 755

页数：6

共 50 条

[31] An Ugi-like Biosynthetic Pathway Encodes Bombesin Receptor Subtype-3 Agonists
Oh, Joonseok
Kim, Nam Y.
Chen, Haiwei
Palm, Noah W.
Crawford, Jason M.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2019, 141 (41) : 16271 - 16278
[32] Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3
J Biol Chem, 22 (13613):
[33] Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3
Ryan, RR
Weber, HC
Hou, W
Sainz, E
Mantey, SA
Battey, JF
Coy, DH
Jensen, RT
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) : 13613 - 13624
[34] Pharmacological characterization of a selective agonist for bombesin receptor subtype-3
Zhang, Li
Nothacker, Hans-Peter
Wang, Zhiwei
Bohn, Laura M.
Civelli, Olivier
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 387 (02) : 283 - 288
[35] The distribution of the orphan bombesin receptor subtype-3 in the rat CNS
Jennings, CA
Harrison, DC
Maycox, PR
Crook, B
Smart, D
Hervieu, GJ
NEUROSCIENCE, 2003, 120 (02) : 309 - 324
[36] Bombesin receptor subtype-3 modulates plasma insulin concentration
Matsumoto, K
Yamada, K
Wada, E
Hasegawa, T
Usui, Y
Wada, K
PEPTIDES, 2003, 24 (01) : 83 - 90
[37] Antiobesity Effect of MK-5046, a Novel Bombesin Receptor Subtype-3 Agonist
Guan, Xiao-Ming
Metzger, Joseph M.
Yang, Liming
Raustad, Kate A.
Wang, Sheng-Ping
Spann, Stephanie K.
Kosinski, Jennifer A.
Yu, Hong
Shearman, Lauren P.
Faidley, Terry D.
Palyha, Oksana
Kan, Yanqing
Kelly, Theresa M.
Sebhat, Iyassu
Lin, Linus S.
Dragovic, Jasminka
Lyons, Kathy A.
Craw, Stephanie
Nargund, Ravi P.
Marsh, Donald J.
Strack, Alison M.
Reitman, Marc L.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 336 (02): : 356 - 364
[38] Design of selective peptidomimetic agonists for the human orphan receptor BRS-3
Weber, D
Berger, C
Eickelmann, P
Antel, J
Kessler, H
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (10) : 1918 - 1930
[39] Pharmacological characterization of the human bombesin receptor subtype 3 (BRS-3) receptor endogenously expressed in NC1-N417 cells
Smart, D
Ranson, J
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 : U42 - U42
[40] A Combined DFT and QSAR Calculations to Study Substituted Biphenyl imidazoles as Bombesin Receptor Subtype-3 Agonists
Shahlaei, Mohsen
Nowroozi, Amin
Khodarahmi, Reza
LETTERS IN DRUG DESIGN & DISCOVERY, 2014, 11 (05) : 665 - 676

← 1 2 3 4 5 →